Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for inducing mesenchymal stem cells to be directionally differentiated into Leydig cells and application of method

A technology of mesenchymal stem cells and directed differentiation, which is applied in the field of compositions for inducing directed differentiation of mesenchymal stem cells into Leydig cells in vitro, and can solve problems such as insufficient source of seed cells

Active Publication Date: 2017-07-07
THE INST OF BASIC MEDICAL SCI OF CHINESE ACAD OF MEDICAL SCI
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] In this patent application, the inventors disclosed a kind of directed induction of placenta-derived mesenchymal stem cells (MSCs) into Leydig cells that can secrete the androgen testosterone. The Leydig cells can be treated by cell transplantation to solve the shortage of seed cell sources problems to meet clinical needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for inducing mesenchymal stem cells to be directionally differentiated into Leydig cells and application of method
  • Method for inducing mesenchymal stem cells to be directionally differentiated into Leydig cells and application of method
  • Method for inducing mesenchymal stem cells to be directionally differentiated into Leydig cells and application of method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 Acquisition of Flk1+ Mesenchymal Stem Cells (Flk1+MSC) and Verification of Differentiation Ability

[0038] In order to evaluate the clinical application value of Flk1+MSCs, we firstly verified their differentiation ability.

[0039] Placental tissue was obtained from the Department of Obstetrics and Gynecology, Peking Union Medical College Hospital. Sterile placental tissue blocks were obtained after caesarean section. The collected adipose tissue was washed with D-Hanks to remove blood cells and anesthetics, repeated several times, cut into 1-2mm rice grain size with tweezers, scissors, etc., digested with 0.2% type II collagenase for 1.5-2 hours, and then washed with D-Hanks 2 times to remove collagenase. Cells were collected by centrifugation at 2 × 10 6 / ml density inoculated in 58% DMEM / F12+40% MCDB-201, 5% fetal calf serum (FCS), 10ng / ml EGF, 10ng / ml PDGF, 1 × insulin-transferrin-selenous acid ( Insulin-Transferrin-Selenium, ITS), 1×linoleic acid-bovi...

Embodiment 2

[0042] Example 2: Identification of placenta-derived Flk1+MSC immunophenotype (detection by flow cytometry)

[0043] (1) Indirect immunofluorescence staining was used for staining, and flow cytometry was used for detection. The cells in good condition of the second generation were collected and digested with 0.125% EDTA trypsin (containing 0.01% EDTA) routinely;

[0044] (2) After the cells are evenly dispersed, take a small amount of cell suspension and count, transfer the remaining cells to a centrifuge tube, and centrifuge at 1200rpm for 5 minutes;

[0045] (3) Discard the supernatant, collect the cell pellet, flick the bottom of the tube to disperse the cells, resuspend with D-hank’s, and dispense into flow tubes, about 5×105 cells per tube;

[0046] (4) Add the primary antibody and incubate at 4°C for 30 minutes. The primary antibodies were CD73, CD90, CD29, CD34, CD31, CD44, CD105, HLA-DR and Flk1 (cells were fixed with BD’s Cytofix / CytopermTM Fixation / Permeabilization...

Embodiment 3

[0052] Example 3: Staining identification of placenta-derived Flk1+MSC adipogenic and osteogenic induction

[0053] Adipogenic Induction Process of Placenta-Derived MSCs

[0054] (1) Take the second-generation human placenta-derived mesenchymal stem cells, routinely digest and count them, and inoculate them in six-well plates or culture dishes at a density of 2×104 / cm2;

[0055] (2) Observe the growth of the cells, and when the growth reaches 80% confluence, replace the culture medium with an adipogenic induction medium to continue culturing;

[0056] (3) The culture medium was changed every three days, and the changes of cell morphology and the formation of intracellular lipid droplets were observed under an inverted microscope.

[0057] Osteogenic Induction Process of Placenta-Derived MSCs

[0058] (1) Take the second-generation human placenta-derived mesenchymal stem cells, routinely digest and count them, and inoculate them in six-well plates or culture dishes at a densi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for inducing mesenchymal stem cells to be directionally differentiated into Leydig cells and application of the method. Further, the invention relates to a composition for in-vitro inducing mesenchymal stem cells to be directionally differentiated into Leydig cells and application of the composition.

Description

technical field [0001] The invention relates to the field of inducing directed differentiation of mesenchymal stem cells into Leydig cells in vitro. Further, the present invention relates to a composition for inducing directed differentiation of mesenchymal stem cells into Leydig cells in vitro. Background technique [0002] Stem cells are the source of tissue regeneration. Stem cells can be divided into embryonic stem cells (ESCs) and adult stem cells (ASCs) according to the order in which they appear during individual development; It is divided into totipotent stem cells (totipotent stem cel1), multipotent stem cells (pluripotent stem cel1), multipotent stem cells (multipotent stem cel1) and unipotent stem cells (unipotent stem cel1). Adult stem cells can also be divided into hematopoietic stem cells, bone marrow mesenchymal stem cells, neural stem cells, muscle stem cells, etc. according to the tissue source. Through gene transfection technology, certain transcription f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/071C12N5/0775
CPCC12N5/0683C12N2501/105C12N2501/135C12N2501/2301C12N2501/31C12N2506/1346
Inventor 赵春华毛晓晶
Owner THE INST OF BASIC MEDICAL SCI OF CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com